Institutional investors purchased a net $1.3 million shares of OMER during the quarter ended June 2016, and now own 48.78% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HIGHMARK CAPITAL MANAGEMENT, INC... Sold 520.00 shares of Omeros Corp